Investing
CapEx
Gilead Sciences CapEx decreased by 42.9% to $117.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.5%, from $104.00M to $117.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a -0.7% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Detailed definition
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Peer comparison
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
Metric ID:
capital_expendituresHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $119.00M | $139.00M | $156.00M | $247.00M | $143.00M | $157.00M | $181.00M | $109.00M | $139.00M | $122.00M | $215.00M | $105.00M | $130.00M | $141.00M | $147.00M | $104.00M | $107.00M | $147.00M | $205.00M | $117.00M |
| QoQ Change | — | +16.8% | +12.2% | +58.3% | -42.1% | +9.8% | +15.3% | -39.8% | +27.5% | -12.2% | +76.2% | -51.2% | +23.8% | +8.5% | +4.3% | -29.3% | +2.9% | +37.4% | +39.5% | -42.9% |
| YoY Change | — | — | — | — | +20.2% | +12.9% | +16.0% | -55.9% | -2.8% | -22.3% | +18.8% | -3.7% | -6.5% | +15.6% | -31.6% | -1.0% | -17.7% | +4.3% | +39.5% | +12.5% |
Range$104.00M – $247.00M
CAGR-0.4%
Avg YoY Growth-0.1%
Median YoY Growth+1.7%
CapEx at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's capex?
- Gilead Sciences (GILD) reported capex of $117.00M in Q1 2026.
- How has Gilead Sciences's capex changed year-over-year?
- Gilead Sciences's capex increased by 12.5% year-over-year, from $104.00M to $117.00M.
- What is the long-term trend for Gilead Sciences's capex?
- Over 4 years (2021 to 2025), Gilead Sciences's capex has grown at a -0.7% compound annual growth rate (CAGR), from $579.00M to $563.00M.
- What does capex mean?
- The money spent on long-term physical assets like machinery, data centers, and office buildings.